Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
The Journal of Nutrition
|
August 1, 2025
Physiologically Based Pharmacokinetic Modeling of Vitamin B-12 Incorporating Mechanistic Absorption: An Example Application for Intake Estimation During Pregnancy
Mian Zhang, Lisa M Almond, Hannah M Jones
CPT: Pharmacometrics & Systems Pharmacology
|
September 16, 2024
A tutorial on physiologically based pharmacokinetic approaches in lactation research
Amita Pansari, Xian Pan, Lisa M Almond, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 12, 2023
Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example
Xian Pan, Khaled Abduljalil, Lisa M Almond, et al.
The Journal of Antimicrobial Chemotherapy
|
September 6, 2005
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals
Lisa M Almond, Patrick G Hoggard, Damitha Edirisinghe, et al.
Clinical Pharmacology and Therapeutics
|
March 16, 2022
Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19
Eunjin Hong, Lisa M Almond, Peter S Chung, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 31, 2024
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women
Jia Ning, Amita Pansari, Karen Rowland Yeo, et al.
Clinical Pharmacology and Therapeutics
|
August 9, 2005
Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals
Lisa M Almond, Damitha Edirisinghe, Mark Dalton, et al.
Clinical and Translational Science
|
July 18, 2024
PBPK-led assessment of antimalarial drugs as candidates for Covid-19: Simulating concentrations at the site of action to inform repurposing strategies
Nada Abla, Lisa M Almond, Jennifer J Bonner, et al.
Clinical Pharmacology and Therapeutics
|
June 13, 2020
Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling
Karen Rowland Yeo, Mian Zhang, Xian Pan, et al.
Clinical Pharmacokinetics
|
November 18, 2011
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance
Cyrus Ghobadi, Trevor N Johnson, Mohsen Aarabi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
The Journal of Nutrition
|
August 1, 2025
Physiologically Based Pharmacokinetic Modeling of Vitamin B-12 Incorporating Mechanistic Absorption: An Example Application for Intake Estimation During Pregnancy
Mian Zhang, Lisa M Almond, Hannah M Jones
CPT: Pharmacometrics & Systems Pharmacology
|
September 16, 2024
A tutorial on physiologically based pharmacokinetic approaches in lactation research
Amita Pansari, Xian Pan, Lisa M Almond, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 12, 2023
Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example
Xian Pan, Khaled Abduljalil, Lisa M Almond, et al.
The Journal of Antimicrobial Chemotherapy
|
September 6, 2005
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals
Lisa M Almond, Patrick G Hoggard, Damitha Edirisinghe, et al.
Clinical Pharmacology and Therapeutics
|
March 16, 2022
Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19
Eunjin Hong, Lisa M Almond, Peter S Chung, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 31, 2024
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women
Jia Ning, Amita Pansari, Karen Rowland Yeo, et al.
Clinical Pharmacology and Therapeutics
|
August 9, 2005
Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals
Lisa M Almond, Damitha Edirisinghe, Mark Dalton, et al.
Clinical and Translational Science
|
July 18, 2024
PBPK-led assessment of antimalarial drugs as candidates for Covid-19: Simulating concentrations at the site of action to inform repurposing strategies
Nada Abla, Lisa M Almond, Jennifer J Bonner, et al.
Clinical Pharmacology and Therapeutics
|
June 13, 2020
Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling
Karen Rowland Yeo, Mian Zhang, Xian Pan, et al.
Clinical Pharmacokinetics
|
November 18, 2011
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance
Cyrus Ghobadi, Trevor N Johnson, Mohsen Aarabi, et al.
Page
of 2